Table 1.
Compounds | R1 | R2 | ClogPa | MICb (μg/mL) | (μg/mL) | SId (IC50/MIC) |
---|---|---|---|---|---|---|
V | H | / | / | >50 | / | / |
VI | H | H | / | 6.25 | / | / |
2a | H | H | −0.01 | 6.25 | 143.6 | 23 |
2b | H | -CH3 | 0.49 | 12.5 | / | / |
2c | H | -OMe | −0.09 | 12.5 | / | / |
2d | H | -F | 0.14 | 3.13 | 122.8 | 39.2 |
2e | H | -Cl | 0.71 | 3.13 | 115.7 | 37 |
2f | H | / | −1.54 | 25 | / | / |
2g | CH3 | H | 0.49 | 12.5 | / | / |
2h | CH3 | -CH3 | 0.99 | 25 | / | / |
2i | CH3 | -OMe | 0.41 | 50 | / | / |
2j | CH3 | -F | 0.64 | 6.25 | 113.5 | 18.2 |
2k | CH3 | -Cl | 1.21 | 3.13 | 102.2 | 32.7 |
2l | OCH3 | H | 0.26 | 100 | / | / |
2m | OCH3 | -CH3 | 0.76 | 100 | / | / |
2n | OCH3 | -OMe | 0.18 | 200 | / | / |
2o | OCH3 | -F | 0.40 | 50 | / | / |
2p | OCH3 | -Cl | 0.97 | 50 | / | / |
2q | F | H | 0.29 | 6.25 | 126.4 | 20.2 |
2r | F | -CH3 | 0.79 | 12.5 | / | / |
2s | F | -OMe | 0.21 | 25 | / | / |
2t | F | -F | 0.43 | 1.56 | 100.9 | 64.7 |
2u | F | -Cl | 1.00 | 1.56 | 91.2 | 58.5 |
2v | Cl | H | 0.86 | 3.13 | 118.8 | 38 |
2w | Cl | -CH3 | 1.36 | 6.25 | 125.3 | 20 |
2x | Cl | -OMe | 0.78 | 12.5 | / | / |
2y | Cl | -F | 1.00 | 1.56 | 106.8 | 68.5 |
2z | Cl | -Cl | 1.57 | 1.56 | 94.6 | 60.6 |
RMPe | / | / | / | 0.125 | / | / |
Calculated by SYBYL-X 2.0 (Tripos, Inc.).
Actual minimum inhibitory concentration (MABA assay).
Measurement of cytotoxicity in VERO cells.
Selectivity index.
Rifampicin.